Gold prices edge higher on raised Fed rate cut hopes
Investing.com - Jefferies initiated coverage on Sartorius AG (ETR:SATG) (ETR:SRT) (OTC:SARTF) with a Buy rating and set a price target of EUR210.00.
The research firm highlighted that investors can access Sartorius’ businesses through three listed equity securities: ordinary shares (SRT) and preference shares (SRT3) on the Frankfurt exchange, plus Sartorius Stedim (EPA:STDM) Biotech (EPA:DIM) shares listed in Paris.
Sartorius AG owns approximately 71.5% of Sartorius Stedim Biotech shares and about 83% of its voting rights, consolidating the financials between the entities.
Jefferies launched coverage on the ordinary shares despite their low liquidity and limited free-float, aiming to assess ownership implications ahead of upcoming changes to the joint heirship in 2028.
The firm expects relative value between Sartorius’ preference shares (SRT3) and Sartorius Stedim Biotech (DIM) to become an increasing focus for investors.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.